Bank of America

Investment grade corporate bond market players only had to wait one day for the first new deals of 2018. Renault and BMW both brought new paper to market on Wednesday, selling a total of €2.75bn of bonds with little premium.

European retail-targeted equity funds, in aggregate, sold some of their positions during December, but year to date flows were still positive for the asset class.

Swire Properties is set to become Asia ex-Japan's first issuer of international bonds in the new year, opening books for a 10 year dollar green deal on Wednesday morning.

The European high yield bond market may have endured a year of multi-billion outflows from retail funds but investors and bankers on the first business week of 2018 are predicting a busy first quarter of supply will be met with sufficient demand.

Hong Kong’s Swire Properties is gearing up to become one of the first offshore bond issuers of the year, taking feedback from the market for a potential dollar-denominated green deal.

Dealogic could be one of the last leveraged loan deals to close in 2017. With allocations of its dividend recapitalisation loans due on Friday, the deal is likely to cap what has been an all-time record year of issuance in the European leveraged loan market.

Chinese technology company JD.com has doubled its maiden offshore loan to $1bn, thanks to commitments from 18 lenders during primary syndication.

HDFC Asset Management Co will work with Bank of America Merrill Lynch, Citi and Kotak Mahindra Capital as the leads on its IPO, according to bankers close to the transaction.

Reliance Industries has allocated its $2.49bn multi-tranche fundraising among 31 banks, with plans to transfer in the new lenders before the end of the year, said bankers close to the trade.

Shareholders have piled into China Power International Development’s HK$4.5bn ($573m) rights issue, putting in orders for double the amount of available stock.

Abu Dhabi National Oil Co’s $850m flotation of its petrol station chain Adnoc Distribution has been greeted warmly by the market, setting a good precedent for an expected wave of privatisations in the Middle East. Sam Kerr reports.

WuXi Biologics Holdings, which listed in Hong Kong in June in a hugely popular IPO, raised HK$5.07bn ($649m) from a block trade that was increased in size on the back of strong investor demand.